Valuation: Crossject

Market Cap 86.02M 100M 80.7M 73.74M 139M 9.57B 140M 955M 371M 4.83B 376M 368M 15.97B P/E 2026 *
3.85x
P/E 2027 * 3.04x
Enterprise Value 68.12M 79.4M 63.91M 58.4M 110M 7.58B 111M 756M 293M 3.82B 298M 292M 12.64B EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.92x
Free-Float
91.83%
Yield 2026 *
-
Yield 2027 * -
1 day+6.76%
1 week+9.42%
Current month+5.33%
1 month+5.05%
3 months-29.15%
6 months-24.76%
Current year-27.85%
1 week 1.35
Extreme 1.348
1.6
1 month 1.35
Extreme 1.348
1.6
Current year 1.35
Extreme 1.348
2.58
1 year 1.35
Extreme 1.346
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
8.35
Manager TitleAgeSince
Chief Executive Officer 63 2001-08-07
Director of Finance/CFO - 2026-03-24
Corporate Officer/Principal - 2024-08-19
Director TitleAgeSince
Chairman 67 2009-06-25
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
7/4/25 Buy

Director

13,386 0.0266%
7/1/25 Buy

Director

50 0.0001%
7/1/25 Buy

Director

337 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+6.76%+9.42%+6.04%-60.50% 94.03M
+5.66%+19.59%-21.70%-32.63% 126M
-2.48%+2.15%+98.90%+54.10% 90.33M
+4.93%+13.31%+61.29%-11.83% 64.08M
Average +3.72%+10.58%+36.13%-12.72% 93.63M
Weighted average by Cap. +3.85%+10.26%+28.55%-15.15%

Financials

2026 *2027 *
Net sales 60.8M 70.87M 57.04M 52.12M 98.32M 6.76B 98.66M 675M 262M 3.41B 266M 260M 11.28B 42.3M 49.3M 39.68M 36.26M 68.4M 4.7B 68.64M 470M 182M 2.37B 185M 181M 7.85B
Net income 28.3M 32.99M 26.55M 24.26M 45.76M 3.15B 45.92M 314M 122M 1.59B 124M 121M 5.25B 7.75M 9.03M 7.27M 6.64M 12.53M 862M 12.58M 86.04M 33.38M 435M 33.9M 33.16M 1.44B
Net Debt -17.9M -20.86M -16.79M -15.34M -28.95M -1.99B -29.04M -199M -77.1M -1B -78.31M -76.6M -3.32B -47M -54.78M -44.09M -40.29M -76M -5.23B -76.26M -522M -202M -2.64B -206M -201M -8.72B
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
26-08-26 €1.580 +6.76% 661,932
26-08-25 €1.480 +3.50% 204,084
26-08-24 €1.430 +1.27% 463,718
26-08-21 €1.412 -2.22% 210,322
26-08-20 €1.444 0.00% 168,911
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.580EUR
Average target price
4.400EUR
Spread / Average Target
+178.48%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCJ Stock